Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats ; volume:01 ; number:02 ; year:2016 ; pages:106-110
Journal of reconstructive microsurgery open ; 01, Heft 02 (2016), 106-110
- Contributor
-
Vieira, Fabio Antonio
Fernandes, Marcela
Valente, Sandra Gomes
Nakachima, Luis Renato
Fernandes, Carlos Henrique
Dos Santos, João Baptista Gomes
- DOI
-
10.1055/s-0036-1593403
- URN
-
urn:nbn:de:101:1-2018112112572090827974
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vieira, Fabio Antonio
- Fernandes, Marcela
- Valente, Sandra Gomes
- Nakachima, Luis Renato
- Fernandes, Carlos Henrique
- Dos Santos, João Baptista Gomes
Other Objects (12)
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
The Value Of Fluorescein In Predicting The Viability Of Flaps
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
The Value Of Fluorescein In Predicting The Viability Of Flaps
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
The Value Of Fluorescein In Predicting The Viability Of Flaps
Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy
Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty